Literature DB >> 6471321

Toxicity of over-the-counter stimulants.

P Pentel.   

Abstract

Over-the-counter stimulants (phenylpropanolamine hydrochloride, ephedrine, pseudoephedrine, caffeine) are used widely as decongestants, anorectic agents, amphetamine substitutes, and "legal stimulants." Toxic effects may result from overdose, drug interactions, or diseases that increase sensitivity to sympathomimetic agents. The most important toxic effect of the alpha-adrenergic agonist phenylpropanolamine is hypertension, which may result in hypertensive encephalopathy or intracerebral hemorrhage. The therapeutic index of phenylpropanolamine is low, and severe hypertension may occur after ingestion of less than three times the therapeutic dose. Ephedrine and pseudoephedrine may also cause hypertension, as well as tachyarrhythmias due to beta-adrenergic stimulation. Toxic reactions from caffeine are characterized by agitation, seizures, tachyarrhythmias, and hypotension. Management of toxic reactions to over-the-counter stimulants includes control of hypertension with a rapidly acting vasodilator, beta-blockers for tachyarrhythmias, and control of seizures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6471321

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  18 in total

1.  Running a risk? Sport supplement toxicity with ephedrine in an amateur marathon runner, with subsequent rhabdomyolysis.

Authors:  Rhys Rhidian
Journal:  BMJ Case Rep       Date:  2011-12-13

2.  Psychosis with Vicks Formula 44-D abuse.

Authors:  D F Craig
Journal:  CMAJ       Date:  1992-04-01       Impact factor: 8.262

Review 3.  Enhancement of athletic performance with drugs. An overview.

Authors:  J C Wagner
Journal:  Sports Med       Date:  1991-10       Impact factor: 11.136

Review 4.  Performance-enhancing substances in sports: a review of the literature.

Authors:  Amit Momaya; Marc Fawal; Reed Estes
Journal:  Sports Med       Date:  2015-04       Impact factor: 11.136

5.  Safety implications regarding use of phytomedicines.

Authors:  Laura Cuzzolin; Silvana Zaffani; Giuseppina Benoni
Journal:  Eur J Clin Pharmacol       Date:  2005-12-03       Impact factor: 2.953

6.  Ephedra and its application to sport performance: another concern for the athletic trainer?

Authors:  M E Powers
Journal:  J Athl Train       Date:  2001-10       Impact factor: 2.860

Review 7.  Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service.

Authors:  Christopher Bryczkowski; Ann-Jeannette Geib
Journal:  J Med Toxicol       Date:  2012-12

8.  A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies.

Authors:  S H Thomas; K L Clark; R Allen; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

9.  Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.

Authors:  S J Sperber; J V Sorrentino; D K Riker; F G Hayden
Journal:  Bull N Y Acad Med       Date:  1989-01

10.  Necroptosis-like Neuronal Cell Death Caused by Cellular Cholesterol Accumulation.

Authors:  Takeshi Funakoshi; Toshihiko Aki; Masateru Tajiri; Kana Unuma; Koichi Uemura
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.